| Literature DB >> 25707511 |
Qinghua Jiang, Rui Ma, Jixuan Wang, Xiaoliang Wu, Shuilin Jin, Jiajie Peng, Renjie Tan, Tianjiao Zhang, Yu Li, Yadong Wang.
Abstract
BACKGROUND: The GENCODE project has collected over 10,000 human long non-coding RNA (lncRNA) genes. However, the vast majority of them remain to be functionally characterized. Computational investigation of potential functions of human lncRNA genes is helpful to guide further experimental studies on lncRNAs.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25707511 PMCID: PMC4331805 DOI: 10.1186/1471-2164-16-S3-S2
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Schematic workflow of the LncRNA2Function.
The top 20 biological processes assigned to the development-regulating HOTAIR by LncRNA2Function.
| GO term | Background frequency | Sample frequency | P-value | Corrected |
|---|---|---|---|---|
| System development | 3253/20447 | 38/74 | 1.63E-12 | 2.37E-08 |
| Anatomical structure morphogenesis | 1884/20447 | 28/74 | 2.45E-11 | 7.10E-08 |
| Tissue development | 1183/20447 | 23/74 | 1.33E-11 | 7.10E-08 |
| Embryonic skeletal system development | 120/20447 | 10/74 | 1.73E-11 | 7.10E-08 |
| Anatomical structure development | 3717/20447 | 39/74 | 2.07E-11 | 7.10E-08 |
| Skeletal system development | 388/20447 | 14/74 | 1.01E-10 | 2.44E-07 |
| Organ morphogenesis | 790/20447 | 18/74 | 2.89E-10 | 4.73E-07 |
| Multicellular organismal development | 3830/20447 | 38/74 | 2.56E-10 | 4.73E-07 |
| Developmental process | 4248/20447 | 40/74 | 2.93E-10 | 4.73E-07 |
| Organ development | 2271/20447 | 29/74 | 3.63E-10 | 5.27E-07 |
| Skeletal system morphogenesis | 189/20447 | 10/74 | 1.54E-09 | 1.72E-06 |
| Multicellular organismal process | 5336/20447 | 44/74 | 1.39E-09 | 1.72E-06 |
| Single-multicellular organism process | 5125/20447 | 43/74 | 1.51E-09 | 1.72E-06 |
| Extracellular matrix organization | 204/20447 | 10/74 | 3.23E-09 | 3.28E-06 |
| Extracellular structure organization | 205/20447 | 10/74 | 3.39E-09 | 3.28E-06 |
| Head development | 52/20447 | 6/74 | 3.26E-08 | 2.96E-05 |
| Embryonic skeletal system morphogenesis | 91/20447 | 7/74 | 3.86E-08 | 3.30E-05 |
| Single-organism developmental process | 3161/20447 | 31/74 | 4.39E-08 | 3.54E-05 |
| Chordate embryonic development | 557/20447 | 13/74 | 9.05E-08 | 6.57E-05 |
| Embryo development ending in birth or egg hatching | 564/20447 | 13/74 | 1.05E-07 | 7.23E-05 |
The metastasis-associated HOTAIR was annotated with metastasis-related GO and pathway terms by LncRNA2Function.
| Database | Functional term | Background frequency | Sample frequency | P-value | Corrected P-value |
|---|---|---|---|---|---|
| GO | Locomotion | 1022/20447 | 14/74 | 1.53E-05 | 0.003417 |
| GO | Cell migration | 603/20447 | 10/74 | 6.07E-05 | 0.010887 |
| GO | Cell adhesion | 790/20447 | 11/74 | 1.21E-04 | 0.020655 |
| GO | Biological adhesion | 792/20447 | 11/74 | 1.24E-04 | 0.020663 |
| GO | Cell motility | 664/20447 | 10/74 | 1.34E-04 | 0.021695 |
| GO | Positive regulation of cell-cell adhesion | 33/20447 | 3/74 | 2.30E-04 | 0.032376 |
| PID | Beta1 integrin cell surface interactions | 75/20447 | 7/74 | 9.92E-09 | 2.22E-06 |
| Reactome | Extracellular matrix organization | 102/20447 | 7/74 | 8.54E-08 | 9.57E-06 |
| KEGG | ECM-receptor interaction | 110/20447 | 7/74 | 1.44E-07 | 1.07E-05 |
| INOH | Integrin | 141/20447 | 7/74 | 7.82E-07 | 4.01E-05 |
| Wikipathways | Focal Adhesion | 203/20447 | 7/74 | 8.79E-06 | 2.46E-04 |
| KEGG | Focal adhesion | 219/20447 | 7/74 | 1.44E-05 | 3.58E-04 |
| PID | Beta3 integrin cell surface interactions | 47/20447 | 4/74 | 2.51E-05 | 5.61E-04 |
| PID | Syndecan-1-mediated signaling events | 50/20447 | 4/74 | 3.21E-05 | 6.53E-04 |
| PID | Integrin cell surface interactions | 58/20447 | 4/74 | 5.78E-05 | 0.001079 |
| PID | Integrins in angiogenesis | 73/20447 | 4/74 | 1.42E-04 | 0.002454 |
| Reactome | Integrin cell surface interactions | 88/20447 | 4/74 | 2.93E-04 | 0.004373 |
| KEGG | PI3K-Akt signaling pathway | 361/20447 | 7/74 | 3.29E-04 | 0.004606 |
| Reactome | Cell surface interactions at the vascular wall | 104/20447 | 4/74 | 5.53E-04 | 0.006566 |
| Reactome | Signaling by PDGF | 187/20447 | 5/74 | 5.86E-04 | 0.006566 |
| Reactome | NCAM1 interactions | 45/20447 | 3/74 | 5.79E-04 | 0.006566 |
| Reactome | NCAM signaling for neurite out-growth | 72/20447 | 3/74 | 0.002268 | 0.023101 |
| Reactome | Platelet Adhesion to exposed collagen | 22/20447 | 2/74 | 0.002848 | 0.025533 |
| PID | VEGFR3 signaling in lymphatic endothelium | 25/20447 | 2/74 | 0.003673 | 0.031645 |
| Reactome | Basigin interactions | 26/20447 | 2/74 | 0.003969 | 0.032935 |
| KEGG | TGF-beta signaling pathway | 92/20447 | 3/74 | 0.004537 | 0.036298 |
| PID | Wnt signaling network | 29/20447 | 2/74 | 0.004924 | 0.038039 |
| Reactome | Degradation of the extracellular matrix | 32/20447 | 2/74 | 0.005974 | 0.043169 |
| Reactome | Activation of Matrix Metalloproteinases | 32/20447 | 2/74 | 0.005974 | 0.043169 |
| PID | Alpha4 beta1 integrin signaling events | 34/20447 | 2/74 | 0.006725 | 0.046835 |
The top 20 biological processes assigned to the AIDS-related lncRNA HCP5 by LncRNA2Function.
| GO term | Background frequency | Sample frequency | P-value | Corrected |
|---|---|---|---|---|
| Immune system process | 1581/20447 | 208/458 | 1.0E-109 | 3.49E-105 |
| Immune response | 867/20447 | 148/458 | 1.57E-90 | 2.70E-86 |
| Defense response | 968/20447 | 144/458 | 2.37E-79 | 2.72E-75 |
| Regulation of immune system process | 879/20447 | 131/458 | 1.16E-71 | 9.95E-68 |
| Regulation of immune response | 527/20447 | 105/458 | 9.62E-70 | 6.62E-66 |
| Response to stimulus | 6195/20447 | 312/458 | 9.35E-64 | 5.36E-60 |
| Cell activation | 557/20447 | 89/458 | 3.11E-50 | 1.53E-46 |
| Leukocyte activation | 344/20447 | 73/458 | 5.00E-50 | 2.15E-46 |
| Regulation of response to stimulus | 2379/20447 | 173/458 | 1.23E-48 | 4.72E-45 |
| Positive regulation of immune system process | 522/20447 | 84/458 | 1.39E-47 | 4.77E-44 |
| Response to stress | 2747/20447 | 181/458 | 4.76E-45 | 1.26E-41 |
| Signal transduction | 3612/20447 | 205/458 | 4.25E-42 | 1.04E-38 |
| Positive regulation of immune response | 331/20447 | 63/458 | 4.17E-40 | 9.56E-37 |
| Cellular response to stimulus | 4596/20447 | 231/458 | 5.11E-40 | 1.10E-36 |
| Lymphocyte activation | 276/20447 | 58/458 | 1.81E-39 | 3.66E-36 |
| Innate immune response | 474/20447 | 72/458 | 6.13E-39 | 1.17E-35 |
| Positive regulation of response to stimulus | 1154/20447 | 106/458 | 6.43E-37 | 1.16E-33 |
| T cell activation | 176/20447 | 46/458 | 5.40E-36 | 9.28E-33 |
| Single organism signaling | 4081/20447 | 208/458 | 1.23E-35 | 1.92E-32 |
| Immune response-regulating signaling pathway | 218/20447 | 49/458 | 6.76E-35 | 1.01E-31 |
The top 20 pathways assigned to AIDS-related lncRNA HCP5 by our LncRNA2Function.
| Pahtway | Pahtway name | Background frequency | Sample frequency | P-value | Corrected P-value |
|---|---|---|---|---|---|
| Reactome | Immune System | 1177/20447 | 98/458 | 1.66E-30 | 2.14E-27 |
| KEGG | Natural killer cell mediated cytotoxicity | 219/20447 | 38/458 | 6.00E-23 | 3.87E-20 |
| PID | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 104/20447 | 28/458 | 1.06E-22 | 4.54E-20 |
| Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 202/20447 | 35/458 | 3.36E-21 | 1.08E-18 |
| Reactome | Adaptive Immune System | 772/20447 | 66/458 | 4.68E-21 | 1.21E-18 |
| NetPath | TCR | 252/20447 | 36/458 | 6.84E-19 | 1.47E-16 |
| KEGG | Chemokine signaling pathway | 195/20447 | 30/458 | 7.56E-17 | 1.39E-14 |
| PID | Generation of second messenger molecules | 15/20447 | 11/458 | 7.96E-16 | 1.28E-13 |
| KEGG | Osteoclast differentiation | 174/20447 | 27/458 | 2.20E-15 | 3.16E-13 |
| PID | TCR signaling in naive CD4+ T cells | 80/20447 | 19/458 | 1.03E-14 | 1.32E-12 |
| PID | TCR signaling in naive CD8+ T cells | 63/20447 | 17/458 | 2.63E-14 | 3.09E-12 |
| PID | IL12-mediated signaling events | 81/20447 | 18/458 | 1.80E-13 | 1.94E-11 |
| KEGG | Cytokine-cytokine receptor interaction | 291/20447 | 31/458 | 6.97E-13 | 6.42E-11 |
| Reactome | Innate Immune System | 542/20447 | 43/458 | 6.96E-13 | 6.42E-11 |
| KEGG | Hematopoietic cell lineage | 114/20447 | 20/458 | 9.26E-13 | 7.97E-11 |
| KEGG | T cell receptor signaling pathway | 116/20447 | 20/458 | 1.30E-12 | 1.05E-10 |
| Reactome | Cell surface interactions at the vascular wall | 104/20447 | 19/458 | 1.62E-12 | 1.23E-10 |
| PID | Cell surface interactions at the vascular wall | 42/20447 | 13/458 | 4.26E-12 | 3.06E-10 |
| Reactome | Class A/1 (Rhodopsin-like receptors) | 319/20447 | 31/458 | 7.85E-12 | 5.33E-10 |
| PID | Fc-epsilon receptor I signaling in mast cells | 64/20447 | 15/458 | 8.34E-12 | 5.38E-10 |
Figure 2The top 25 statistically significant enriched GO biological processes assigned to liver-related HULC are associated with the metabolic function of liver.
Top 20 pathways enriched in protein-coding genes that are co-expressed with the liver-related lncRNA HULC.
| Pahtway | Pahtway name | Background frequency | Sample frequency | P-value | Corrected P-value |
|---|---|---|---|---|---|
| Reactome | Metabolism | 1394/20447 | 128/390 | 6.17E-54 | 6.23E-51 |
| KEGG | Metabolic pathways | 1256/20447 | 109/390 | 7.95E-43 | 4.01E-40 |
| KEGG | Retinol metabolism | 69/20447 | 29/390 | 5.66E-32 | 1.91E-29 |
| KEGG | Complement and coagulation cascades | 87/20447 | 30/390 | 6.18E-30 | 1.56E-27 |
| EHMN | Androgen and estrogen biosynthesis and metabolism | 90/20447 | 30/390 | 2.02E-29 | 4.07E-27 |
| Reactome | Biological oxidations | 151/20447 | 36/390 | 2.71E-29 | 4.55E-27 |
| KEGG | Drug metabolism - cytochrome P450 | 76/20447 | 28/390 | 5.84E-29 | 8.41E-27 |
| KEGG | Metabolism of xenobiotics by cytochrome P450 | 87/20447 | 29/390 | 1.78E-28 | 2.24E-26 |
| KEGG | Chemical carcinogenesis | 86/20447 | 28/390 | 3.33E-27 | 3.74E-25 |
| EHMN | Tyrosine metabolism | 113/20447 | 30/390 | 4.29E-26 | 4.33E-24 |
| EHMN | Xenobiotics metabolism | 54/20447 | 23/390 | 9.33E-26 | 8.56E-24 |
| Reactome | Metabolism of amino acids and derivatives | 159/20447 | 32/390 | 1.09E-23 | 9.20E-22 |
| Wikipathways | metapathway biotransformation | 190/20447 | 34/390 | 2.43E-23 | 1.88E-21 |
| EHMN | Linoleate metabolism | 75/20447 | 24/390 | 2.81E-23 | 2.03E-21 |
| Wikipathways | cytochrome P450 | 68/20447 | 23/390 | 5.40E-23 | 3.63E-21 |
| Wikipathways | Complement and Coagulation Cascades | 60/20447 | 22/390 | 5.97E-23 | 3.77E-21 |
| EHMN | Leukotriene metabolism | 102/20447 | 26/390 | 2.87E-22 | 1.70E-20 |
| Reactome | Phase 1 - Functionalization of compounds | 74/20447 | 23/390 | 5.01E-22 | 2.81E-20 |
| KEGG | Drug metabolism - other enzymes | 53/20447 | 20/390 | 2.85E-21 | 1.51E-19 |
| Reactome | Xenobiotics | 15/20447 | 13/390 | 3.68E-21 | 1.86E-19 |
Figure 3Screenshot of web interface of LncRNA2Function.